case_images: PMC9682147_01
case_images: Treatment timeline. CR, complete response; SD, stable disease; PD, progression disease; PR, partial response; LNs, lymph nodes; RT, radiotherapy; SBRT, stereotactic body radiotherapy.
case_images: fonc-12-1009076-g001.jpg
case_images: PMC9682147_01_fonc-12-1009076-g001.jpg
case_images: f1
case_images: The treatment timeline is shown in  Figure 1 .
case_images: Radiological evaluation at baseline (A1 and B1), 1 (A2 and B2), and 3 (A3 and B3) months from start of alectinib therapy demonstrating an ongoing partial response in the pulmonary and brain metastases.
case_images: fonc-12-1009076-g002.jpg
case_images: PMC9682147_01_fonc-12-1009076-g002.jpg
case_images: f2
case_images: CT and MR scans showed radiological partial response at 1 and 3 months on treatment ( Figure 2 ).